| Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ... Cancer discovery 1 (6), 487-495, 2011 | 998 | 2011 |
| New insights into the role of EMT in tumor immune escape S Terry, P Savagner, S Ortiz‐Cuaran, L Mahjoubi, P Saintigny, JP Thiery, ... Molecular oncology 11 (7), 824-846, 2017 | 407 | 2017 |
| Hypoxia: a key player in antitumor immune response. A review in the theme: cellular responses to hypoxia MZ Noman, M Hasmim, Y Messai, S Terry, C Kieda, B Janji, S Chouaib American Journal of Physiology-Cell Physiology 309 (9), C569-C579, 2015 | 389 | 2015 |
| Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis G Robert, A Descazeaud, N Nicolaïew, S Terry, N Sirab, F Vacherot, ... The Prostate 69 (16), 1774-1780, 2009 | 383 | 2009 |
| The many faces of neuroendocrine differentiation in prostate cancer progression S Terry, H Beltran Frontiers in oncology 4, 60, 2014 | 274 | 2014 |
| The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200 MZ Noman, B Janji, A Abdou, M Hasmim, S Terry, TZ Tan, ... Oncoimmunology 6 (1), e1263412, 2017 | 245 | 2017 |
| Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing D Pflueger, S Terry, A Sboner, L Habegger, R Esgueva, PC Lin, ... Genome research 21 (1), 56-67, 2011 | 242 | 2011 |
| FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data A Sboner, L Habegger, D Pflueger, S Terry, DZ Chen, JS Rozowsky, ... Genome biology 11, 1-19, 2010 | 194 | 2010 |
| Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance G Ploussard, X Durand, E Xylinas, S Moutereau, C Radulescu, A Forgue, ... European urology 59 (3), 422-429, 2011 | 193 | 2011 |
| Class III β-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy G Ploussard, S Terry, P Maillé, Y Allory, N Sirab, L Kheuang, P Soyeux, ... Cancer research 70 (22), 9253-9264, 2010 | 192 | 2010 |
| Oncogene-mediated alterations in chromatin conformation DS Rickman, TD Soong, B Moss, JM Mosquera, J Dlabal, S Terry, ... Proceedings of the National Academy of Sciences 109 (23), 9083-9088, 2012 | 170 | 2012 |
| Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy JL Campos-Fernandes, L Bastien, N Nicolaiew, G Robert, S Terry, ... European urology 55 (3), 600-609, 2009 | 150 | 2009 |
| Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells X Yang, MW Chen, S Terry, F Vacherot, DL Bemis, J Capodice, ... Oncogene 25 (24), 3436-3444, 2006 | 145 | 2006 |
| A human-and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells X Yang, MW Chen, S Terry, F Vacherot, DK Chopin, DL Bemis, ... Cancer research 65 (12), 5263-5271, 2005 | 141 | 2005 |
| Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer S Terry, X Yang, MW Chen, F Vacherot, R Buttyan Journal of cellular biochemistry 99 (2), 402-410, 2006 | 124 | 2006 |
| Increased expression of class III β-tubulin in castration-resistant human prostate cancer S Terry, G Ploussard, Y Allory, N Nicolaiew, F Boissiere-Michot, P Maille, ... British journal of cancer 101 (6), 951-956, 2009 | 117 | 2009 |
| The NF-κB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches? B Paule, S Terry, L Kheuang, P Soyeux, F Vacherot, A de la Taille World journal of urology 25, 477-489, 2007 | 101 | 2007 |
| Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy G Ploussard, N Nicolaiew, C Marchand, S Terry, F Vacherot, D Vordos, ... European urology 65 (1), 154-161, 2014 | 96 | 2014 |
| Hypoxic stress-induced tumor and immune plasticity, suppression, and impact on tumor heterogeneity S Terry, S Buart, S Chouaib Frontiers in immunology 8, 1625, 2017 | 93 | 2017 |
| Neuroendocrine differentiation in prostate cancer: from lab to bedside L Cindolo, M Cantile, F Vacherot, S Terry, A de la Taille Urologia internationalis 79 (4), 287-296, 2007 | 81 | 2007 |
Ralph ButtyanVancouver Prostate Centreprostatecentre.com의 이메일 확인됨
